Epilepsy: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

  NCT07531745· Ionis Pharmaceuticals, Inc.· Source

• Behavioral and Neuronal Correlates of Human Mood States

  NCT06159595· Stanford University· Source

• A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

  NCT07723963· Jazz Pharmaceuticals· Source

• A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

  NCT04666610· UCB Biopharma SRL· Source

• Lily's Grace Temporal Interference

  NCT07520955· University of Wisconsin, Madison· Source

• High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 Years

  NCT07803692· Oregon Health and Science University· Source

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Source

• Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)

  NCT05944692· CREmedical· Source

• A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS

  NCT07728097· Jazz Pharmaceuticals· Source

• A Device to Prevent Unexpected Death in Epilepsy

  NCT07877896· Brigham and Women's Hospital· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Organoids 1
• Mendelian Randomization Analysis 2
• Gene Expression Profiling 2
• Sequence Analysis, RNA 1
• Exome Sequencing 4
• Proteomics 6
• Metabolomics 6
• Mass Spectrometry 6
• Flow Cytometry 1
• Immunohistochemistry 19
• Xenograft Model Antitumor Assays 2
• Positron-Emission Tomography 4
• Magnetic Resonance Imaging 50
• Machine Learning 2
• Cohort Studies 65
• Genome-Wide Association Study 3

See which targets of this disease your abstract mentions, and go to the people working on them.